Press Releases

Imagine a world where those living with Type 1 Diabetes, a chronic illness affecting more than 60 million adults globally, no longer had to deal with regular blood glucose monitoring, daily insulin injections or life-threatening nighttime hypoglycemic events, but...

Eisai Co., Ltd. announced that it has entered into a joint research and development agreement with Personal Genome Diagnostics Inc. for the cancer genetics panel test, and it has initiated the research. In this joint research and development, Eisai and...

Medigene AG , a clinical-stage immuno-oncology company focusing on the development of T cell immunotherapies, announces that it has entered into a research collaboration on novel cancer antigens for highly specific immunotherapies with the Universite de Montreal (UdeM) and...

Signant Health has announced new audit trail reviewing and reporting functionality for its electronic clinical outcome assessment (eCOA) and remote sensor platform, TrialMax®. This new functionality enables authorized personnel to simply and quickly access and explore key audit trail...

SAGA Diagnostics AB, a cancer liquid biopsy and genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients, announces it has entered service agreements with the international pharmaceutical company Servier, based in Paris, France. “These deals...

PHARMASEAL, a new provider of clinical trial management (CTMS) and governance solutions to enter the market, is celebrating a year of significant success, with 2019 marking several important milestones for the company. This includes winning Start-Up of the Year...

Bionetix, a biotech company developing novel oncology drugs; ProQinase, an oncology-focused contract research organization (CRO) recently acquired by Reaction Biology Corporation (Malvern/PA, USA); and MercachemSyncom, a chemistry CRO specializing in medicinal chemistry and comprehensive medicinal chemistry (CMC), announced they...